Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect.

The actions of insulin-like growth factor 1 (IGF-1) on protein turnover and of the IGF-1 receptor (IGF-1R) were examined in skeletal muscle of rats with chronic renal failure (CRF) and sham operated (SO), pair-fed controls. Acidemia was prevented in CRF rats with NaHCO3. Serum IGF-1 and skeletal muscle IGF-1 and IGF-1 mRNA were reduced in CRF rats. Dose-response studies revealed impaired stimulation of protein synthesis and suppressed inhibition of protein degradation by IGF-1 in epitrochlearis muscle of CRF rats. Neither IGF-1 analogues with low affinity to IGF binding proteins nor proteinase inhibitors obliterated the IGF-1 resistance. In CRF rats, skeletal muscle IGF-1R mRNA was increased; displacement ligand binding studies and affinity labeling of the IGF-1R alpha subunit indicated increased total skeletal muscle IGF-1R number with normal affinity. However, both autophosphorylation of the IGF-1R beta subunit (i.e., IGF-1R tyrosine kinase) and the IGF-1R tyrosine kinase activity towards exogenous insulin receptor substrate-1, a natural substrate for IGF-1R tyrosine kinase, were reduced in CRF fats. These data indicate that in skeletal muscle of CRF rats there is resistance to the IGF-1 effects on protein synthesis and degradation and decreased IGF-1 and IGF-1 mRNA levels; IGF-1R mRNA and number are increased; but activity of IGF-1R tyrosine kinase is impaired. This postreceptor defect may be a cause of the skeletal muscle resistance to IGF-1 in CRF.

[1]  D. Fouque,et al.  Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. , 1995, Kidney international.

[2]  J. Kopple.  Effect of nutrition on morbidity and mortality in maintenance dialysis patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[4]  M. Preece,et al.  Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). , 1993, The Journal of clinical endocrinology and metabolism.

[5]  S. E. Knowles,et al.  Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats. , 1993, The Journal of endocrinology.

[6]  J. Kopple,et al.  Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. , 1993, The Journal of clinical investigation.

[7]  T. Meyer,et al.  Intracellular calcium regulates insulin-like growth factor-I messenger ribonucleic acid levels. , 1993, Endocrinology.

[8]  R. Hakim,et al.  The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  M. White,et al.  IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase. , 1993, Endocrinology.

[10]  K. Valerie,et al.  Expression of insulin-like growth factor-1 in uremic rats: growth hormone resistance and nutritional intake. , 1993, Kidney international.

[11]  W. Mitch,et al.  Mechanisms that cause protein and amino acid catabolism in uremia. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  S. Massry,et al.  Chronic renal failure is a state of cellular calcium toxicity. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  G. Lienhard,et al.  Components of signaling pathways for insulin and insulin-like growth factor-I in muscle myoblasts and myotubes. , 1992, Endocrinology.

[14]  K. Bornfeldt,et al.  In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscle. , 1992, Journal of Endocrinology.

[15]  C. Roberts,et al.  Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. , 1991, Molecular endocrinology.

[16]  J. H. Shaw,et al.  The Endocrine Role of Insulin‐Like Growth Factor I , 1991, Acta paediatrica Scandinavica. Supplement.

[17]  Insulin-Like Growth Factors , 1991 .

[18]  R. DiMarchi,et al.  IGF-I–Stimulated Glucose Transport in Human Skeletal Muscle and IGF-I Resistance in Obesity and NIDDM , 1990, Diabetes.

[19]  H. Werner,et al.  Developmental regulation of the rat insulin-like growth factor I receptor gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Alexandrides,et al.  A novel fetal insulin-like growth factor (IGF) I receptor. Mechanism for increased IGF I- and insulin-stimulated tyrosine kinase activity in fetal muscle. , 1989, The Journal of biological chemistry.

[21]  T. Alexandrides,et al.  Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle. , 1989, Endocrinology.

[22]  R. Baxter,et al.  Binding proteins for the insulin-like growth factors: structure, regulation and function. , 1989, Progress in growth factor research.

[23]  J. Jansson,et al.  Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. , 1988, Endocrinology.

[24]  M. Sinha,et al.  Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats. , 1988, The American journal of physiology.

[25]  C. Roberts,et al.  Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[27]  W. Mitch,et al.  Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. , 1987, The Journal of clinical investigation.

[28]  J. Harper,et al.  Changes in protein metabolism of ovine primary muscle cultures on treatment with growth hormone, insulin, insulin-like growth factor I or epidermal growth factor. , 1987, The Journal of endocrinology.

[29]  S. Wassner,et al.  Protein synthesis and degradation in skeletal muscle of chronically uremic rats. , 1986, Kidney international.

[30]  M. Rechler,et al.  The nature and regulation of the receptors for insulin-like growth factors. , 1985, Annual review of physiology.

[31]  M. Czech,et al.  The type I insulin-like growth factor receptor mediates the rapid effects of multiplication-stimulating activity on membrane transport systems in rat soleus muscle. , 1984, The Journal of biological chemistry.

[32]  A. Stiles,et al.  Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Situlin,et al.  Muscle biopsy studies in chronically uremic patients: evidence for malnutrition. , 1983, Kidney international. Supplement.

[34]  W. Mitch,et al.  Comparison of protein synthesis and degradation in incubated and perfused muscle. , 1983, The Biochemical journal.

[35]  J. Massagué,et al.  The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. , 1982, The Journal of biological chemistry.

[36]  L. Phillips,et al.  Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function. , 1981, Metabolism: clinical and experimental.

[37]  E. Rinderknecht,et al.  The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. , 1978, The Journal of biological chemistry.

[38]  R. Furlanetto,et al.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. , 1977, The Journal of clinical investigation.

[39]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[40]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[41]  S. Udenfriend,et al.  A fluorometric method for the estimation of tyrosine in plasma and tissues. , 1957, The Journal of laboratory and clinical medicine.

[42]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .